Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
about
Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generationSperm and oocyte communication mechanisms controlling C. elegans fertilityInsulin-like growth factor-I for the treatment of amyotrophic lateral sclerosisA splicing mutation in the novel mitochondrial protein DNAJC11 causes motor neuron pathology associated with cristae disorganization, and lymphoid abnormalities in miceMicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosisSkeletal Muscle Satellite Cells, Mitochondria, and MicroRNAs: Their Involvement in the Pathogenesis of ALSModulation of astrocytic mitochondrial function by dichloroacetate improves survival and motor performance in inherited amyotrophic lateral sclerosisGene expression profiling for human iPS-derived motor neurons from sporadic ALS patients reveals a strong association between mitochondrial functions and neurodegeneration.Axonal mitochondrial clusters containing mutant SOD1 in transgenic models of ALS.Vascular endothelial growth factor prevents G93A-SOD1-induced motor neuron degeneration.Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis.Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study.Oxidative stress biomarkers in sporadic ALSSeeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors.Cancer as a mitochondrial metabolic disease.Zinc regulates the stability of repetitive minisatellite DNA tracts during stationary phase.Amyotrophic lateral sclerosis: all roads lead to Rome.Skeletal muscle in motor neuron diseases: therapeutic target and delivery route for potential treatments.Dynein disruption perturbs post-synaptic components and contributes to impaired MuSK clustering at the NMJ: implication in ALS.Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons.Mitochondrial dysfunction in SOD1G93A-bearing astrocytes promotes motor neuron degeneration: prevention by mitochondrial-targeted antioxidants.Mitochondria: a therapeutic target in neurodegenerationMitochondrial medicine for neurodegenerative diseases.State of the art and the dark side of amyotrophic lateral sclerosis.Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral SclerosisExperimental models for the study of neurodegeneration in amyotrophic lateral sclerosis.Cerebrospinal Fluid from Sporadic Amyotrophic Lateral Sclerosis Patients Induces Mitochondrial and Lysosomal Dysfunction.Cellular Signature of SIL1 Depletion: Disease Pathogenesis due to Alterations in Protein Composition Beyond the ER Machinery.Early ALS-type gait abnormalities in AMP-dependent protein kinase-deficient mice suggest a role for this metabolic sensor in early stages of the disease.Stress-Induced CDK5 Activation Disrupts Axonal Transport via Lis1/Ndel1/Dynein.Effects of dexpramipexole on brain mitochondrial conductances and cellular bioenergetic efficiency.Analysis of European case-control studies suggests that common inherited variation in mitochondrial DNA is not involved in susceptibility to amyotrophic lateral sclerosis.Treatment with Hydrogen-Rich Saline Delays Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis.Altered in vitro proliferation of mouse SOD1-G93A skeletal muscle satellite cells.Mutation Screening of the CHCHD10 Gene in Chinese Patients with Amyotrophic Lateral Sclerosis.Mitochondrial perturbance and execution of apoptosis in platelet mitochondria of patients with amyotrophic lateral sclerosis.Energy metabolism in ALS: an underappreciated opportunity?Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease.
P2860
Q24314962-1AC52122-C68F-49D1-A21F-EF1453381C8CQ24626882-5F6CDF2D-7986-420B-8D1F-245A1825030AQ24630353-76CED73B-6316-4DF4-9DD1-1EFD569B74C5Q27316380-48037E86-77C0-4242-9665-4EFEF3288194Q27321524-DEA9F444-5B42-45F9-998F-D23A9F9F1F10Q28075355-8285402D-D7EB-4C76-A7A4-08915A76150CQ28482111-6D37B37E-26A6-49DC-9817-5EC1DEC44067Q30659873-3687B5E6-3377-4187-90D4-E2C7D92CA221Q33742751-C3E8E88A-15CA-472E-A8FF-19261428F02CQ33782744-33E24138-8269-4835-9913-4D12CF658FD5Q33985590-E3511AF3-52C6-4168-BD66-6E104B0D75DEQ34640994-3E17ECBD-BBD1-4103-A79D-26306C19E53CQ34978980-45DF9CB0-AEF2-45BE-8AA6-9DA65D8B6F86Q35094635-763B13A2-A337-4346-A364-D9A1D7D5BD89Q35802837-EEE62FB9-0E0C-4298-8E50-586F8568CCE9Q35819129-72C8EB0F-1BBA-4357-B149-1CBC52968F73Q35824628-D7820AA1-37DB-44CA-8B63-16541BB394D8Q36416305-C6441320-5995-4A56-86FA-2108C01A1790Q36717512-C53810C3-1AFC-423E-BE1D-37B4A625088DQ36805205-2D5AF5BA-BCC0-4B5B-963B-0C82E4D5F1F5Q36990596-F39EE247-FF6E-499B-9FAB-5EC8EAAE5A95Q37165781-2DC0BEA2-2217-4D4E-A52A-EF975C28E2CEQ37352307-EEC0E91A-543F-4C30-9ABA-3C64D653B7ACQ37466059-7F1369A8-D43C-4A59-B8D1-EB5A0D47674FQ37672741-727FA0BB-08F9-4283-BA4A-B051BA94488CQ37871837-F699DEC2-8CE5-46EA-9948-44B07786645DQ39316849-3C6A6DCC-1644-48F2-AF4C-2AD168FB767BQ39823079-CF695273-49C1-4C8C-A3A1-4912B06D5EB5Q40233562-C78EF1F0-B332-47A7-B925-D41ED0BB7EA5Q40430593-CB897087-C428-44A1-AF93-A2BD327C6AE0Q40760240-534B692B-2784-45D2-BB38-AC949436155BQ41780599-376A5873-2843-453A-84A4-D7E5C462D725Q42153700-05FC4017-6401-4E70-8B88-48DDE9EC9AFCQ42639602-CD37F653-4169-4007-8406-9E72AC26F67BQ46643762-CADC5D92-07B5-45EE-AD5E-0C3B46A31CECQ47383532-1D46A170-3CE8-4429-93A1-63559D09BB23Q47833173-FE913D7F-5DDD-472E-8945-99974EDD01A2Q50552369-52D8252D-5FA2-4530-BADE-032400662FA8Q52651163-71D64120-CEBA-4D8D-A777-31080508A9F7Q55423762-38ED4AE1-636F-4451-BD3E-772087F5A68F
P2860
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
@ast
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
@en
type
label
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
@ast
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
@en
prefLabel
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
@ast
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
@en
P2093
P2860
P356
P1476
Mitochondria in amyotrophic lateral sclerosis: a trigger and a target.
@en
P2093
Hugues Oudart
Jean-Philippe Loeffler
Jose-Luis Gonzalez de Aguilar
Luc Dupuis
Luis Barbeito
Marc de Tapia
P2860
P304
P356
10.1159/000085063
P577
2004-01-01T00:00:00Z